These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24259699)

  • 1. Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.
    Harris K; Smith L
    Ann Pharmacother; 2013 Oct; 47(10):1348-52. PubMed ID: 24259699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.
    Nkontchou G; Cosson E; Aout M; Mahmoudi A; Bourcier V; Charif I; Ganne-Carrie N; Grando-Lemaire V; Vicaut E; Trinchet JC; Beaugrand M
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2601-8. PubMed ID: 21752887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.
    Arase Y; Kobayashi M; Suzuki F; Suzuki Y; Kawamura Y; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Kobayashi T
    Hepatology; 2013 Mar; 57(3):964-73. PubMed ID: 22991257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
    Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
    Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
    Sacco M; Ribaldone DG; Saracco GM
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
    Boland CL; Degeeter M; Nuzum DS; Tzefos M
    Ann Pharmacother; 2013 Apr; 47(4):490-505. PubMed ID: 23548652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.
    Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R
    Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.
    Doyle MA; Singer J; Lee T; Muir M; Cooper C
    Trials; 2016 Jul; 17(1):331. PubMed ID: 27439433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
    Chen TM; Lin CC; Huang PT; Wen CF
    J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
    Masuzaki R; Yoshida H; Omata M
    Oncology; 2010 Jul; 78 Suppl 1():17-23. PubMed ID: 20616579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
    Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
    J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C and hepatocellular carcinoma.
    Fassio E
    Ann Hepatol; 2010; 9 Suppl():119-22. PubMed ID: 20714008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin as adjuvant treatment in hepatitis C virus infections and associated complications.
    Landis D; Sutter A; Khemka S; Songtanin B; Nichols J; Nugent K
    Am J Med Sci; 2024 Aug; 368(2):90-98. PubMed ID: 38701970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
    Kawaguchi T; Taniguchi E; Morita Y; Shirachi M; Tateishi I; Nagata E; Sata M
    Liver Int; 2010 Mar; 30(3):479-86. PubMed ID: 20040053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
    Desbois AC; Cacoub P
    World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
    Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
    Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.